(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
KENNETH A. FOON and ALTON C. MORGAN, JR. Passive immunotherapy using heteroantisera for the treatment of cancer in animals and humans has been studied for over 50 years. Attempts have been made to treat animal tumors with sera from immunized syngeneic, allogeneic, or xenogeneic animals. A number of studies of passive immunotherapy using heterologous antisera in humans have also been performed. These studies have generally been attempted in patients with large tumor burdens, and as would be expected, results have been transient at best. A wide variety of solid tumors as well as leukemias and lym- phomas have been treated with antisera raised in sheep, horses, rabbits, and goats. Problems such as anaphylaxis, serum sick- ness, and severe cytopenias have been encountered with these antisera. There are a number of potential mechanisms by which unconju- gated antibodies might be cytotoxic to tumor cells. Antibodies bound to the cell surface membrane of tumor cells may lead to cell lysis by complement-dependent or antibody-dependent cellu- lar cytotoxicity. Circulating tumor cells bound by antibody may be more susceptible to phagocytosis by the reticuloendothelial system.
Antibody bound to the cell surface membrane of tumor cells may enhance immunogenicity of the tumor cell leading to activation of the host's immune system.
Contents:
1. Monoclonal Antibody Therapy of Cancer: Parameters Which Affect the Efficacy of Immunotoxins.- 2. Design and Development of Drug-Monoclonal Antibody 791T/36 Conjugate for Cancer Therapy.- 3. Monoclonal Antibodies Directed Towards Growth-Related Receptors on Human Tumors.- 4. Monoclonal Antibody Therapy for Patients with Leukemia and Lymphoma.- 5. Monoclonal Antibody Therapy of Solid Tumors.- 6. Human Immune Responses to Murine Monoclonal Antibodies.- 7. Radiolabeled Monoclonal Antibodies for Imaging and Therapy.
PRODUCT DETAILS
Publisher: Springer (Springer-Verlag New York Inc.)
Publication date: February, 2012
Pages: 180
Weight: 284g
Availability: Available
Subcategories: Oncology
From the same series
Dirk J. Ruiter
R. Verley
H.F. Seigler
Kenneth V. Honn
Franco M. Muggia
P. Hilgard
Noburo Kobayashi
James M. Church
L. Dogliotti
A. Giacosa
Seymour Garte
John Masters
Kintomo Takakura
B.A. Stoll
J. Mark Elwood
Laurence H. Baker
Laurence H. Baker
George D. Demetri
B.A. Stoll
A. Giacosa
Franco M. Muggia
Matthew J. van Zwieten
L.A. Liotta
P.I. Reed
Paul H. Sugarbaker
Gabriel A. Kune
Frederick A. Valeriote
R. Ceriani
B. Lowenberg
D.G. Poplack
J. Bánóczy
Thomas R. Tritton
Miles P. Hacker
Aaron Polliack
B. Lowenberg
Pelayo Correa
Alexander H.G. Paterson
Franco M. Muggia
J. Aisner
Stephen T. Sonis
F.J. Cleton
Kenneth V. Honn
Stephen T. Sonis
Soldano Ferrone
Stephen B Howell
C.C. Tijssen
B.W. Hancock
B.W. Ongerboer de Visser
A.P.M. Heintz
B.A. Stoll
A.M. Ward
Daniel L. Kisner
Marvin A. Rich
J. Gordon McVie
J.R. Ryan
Marvin A. Rich
Kenneth V. Honn
D.G. Poplack
Anthony J. Mastromarino
Frederick A. Valeriote
Marvin A. Rich
Laurence H. Baker
P.K. Pattengale
G.B. Snow
Frederick A. Valeriote